2025 annual financial data
Dermata Therapeutics 2025 Operating margin
Dermata Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -7,773,598 USD and net income was -7,558,557 USD.
Operating cash flow was -7,757,559,000 USD.
Get free Dermata Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,773,598 USD
- Net income
- -7,558,557 USD
- Operating cash flow
- -7,757,559,000 USD